Prestige BioPharma Limited (KRX:950210)
South Korea
· Delayed Price · Currency is KRW 13,990
+90 (0.65%)
At close: May 13, 2025, 3:30 PM KST
Prestige BioPharma Market Cap
Prestige BioPharma has a market cap or net worth of 167.07 billion as of May 13, 2025. Its market cap has increased by 70.34% in one year.
Market Cap
167.07B
Enterprise Value
202.21B
Revenue
5.87B
Ranking
n/a
PE Ratio
n/a
Stock Price
13,990.00
Market Cap Chart
Since May 28, 2021, Prestige BioPharma's market cap has decreased from 360.58B to 167.07B, a decrease of -53.67%. That is a compound annual growth rate of -17.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 168.15B | -7.41% |
| Dec 30, 2024 | 181.61B | 59.39% |
| Dec 28, 2023 | 113.94B | 29.33% |
| Dec 29, 2022 | 88.10B | -64.84% |
| Dec 30, 2021 | 250.60B | -30.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 70.53T |
| Celltrion | 32.36T |
| ALTEOGEN | 17.91T |
| Yuhan | 7,864.20B |
| HLB Co., Ltd. | 7,463.37B |
| SK Biopharmaceuticals | 6,930.72B |
| PharmaResearch | 4,135.08B |
| Peptron | 3,983.85B |